𝔖 Bobbio Scriptorium
✦   LIBER   ✦

1006 Levetiracetam in the treatment of levodopa induced dyskinesia-a pilot study

Book ID
122748058
Publisher
Elsevier Science
Year
2005
Tongue
English
Weight
248 KB
Volume
238
Category
Article
ISSN
0022-510X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Open-label pilot study of levetiracetam
Open-label pilot study of levetiracetam (Keppra) for the treatment of levodopa-induced dyskinesias in Parkinson's disease
✍ Theresa A. Zesiewicz; Kelly L. Sullivan; John L. Maldonado; William O. Tatum; Ro πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 69 KB πŸ‘ 1 views

## Abstract We evaluated the tolerability and preliminary efficacy of levetiracetam (LEV; Keppra) in reducing levodopa‐induced dyskinesias in Parkinson's disease (PD) in an open‐label pilot study. Nine PD patients who were experiencing peak‐dose dyskinesias for at least 25% of the awake day and wer

High-dose pergolide monotherapy in the t
High-dose pergolide monotherapy in the treatment of severe levodopa-induced dyskinesias
✍ Alicia Facca; Juan Sanchez-Ramos πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 348 KB

## High-Dose Pergolide Monotherapy in the Treatment of Severe Levodopa-Induced Dyskinesias To the Editor: The development of severe, incapacitating, involuntary movements elicited by chronic dopamine replacement therapy in patients with Parkinson's disease (PD) represents one of the most challeng